Much of the cutting-edge research into WM takes place internationally.

Centres such as Dana Farber Cancer Institute in Boston, USA, in its association with the Bing Centre for Waldenstrom’s Macroglobulinemia ( are leading the way in the development and testing of new treatments.

The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a significant funder of WM research and has taken a leading role in identifying the priorities for WM research. In 2015, the IWMF and the Leukemia and Lymphoma Society (LLS) brought together an international group of researchers, doctors, and industry representatives to develop a Strategic Research Roadmap Initiative for WM.

Strategic Research Roadmap Initiative research priorities:

  • Signalling – what pathways do WM cells use for communication?

  • Immunology/immunotherapy – how can we better use our own immune system to fight WM?

  • Tumour microenvironment – how does the bone marrow / tumour environment affect WM cells?

  • ‘Omics’ – what else can we learn about genomics, epigenomics, and mutations in WM cells?

Read more about the research priorities.

Read about research projects funded under the Strategic Research Roadmap Initiative.

WM researchers from around the world come together at a biannual International Workshop on WM to share their research findings and collaborate on new approaches. 

Each year the IWMF puts out a request for proposals (RFP) for research to help move the scientific communities’ knowledge of WM further along and create medical treatments that help WM patients live longer and have a better quality of life. The WMFC partners with the IWMF and supports a project or projects that have been identified by the IWMF Scientific Committee as an important next step in unravelling the mystery of WM.


Donate today:

Join the WMFC and stay in the loop!

Get the latest news, events and membership information via email.